Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
EMA approved
Mirikizumab is approved by both the FDA and EMA for the treatment of moderately to severely active ulcerative colitis (UC) in adults (1, 2)
Mirikizumab is dosed intravenously during induction and subcutaneously during maintenance. It is effective for the induction and maintenance of remission in moderately to severely active Ulcerative colitis (UC), including patients with prior failure of biological or tofacitinib therapy. Like other [IL-23 antagonists](brain://RZpQIpjWAkyZyJw2TSv9Lw/Interleukin23Il…